Search company, investor...

Athlomics

athlomics.com

Stage

Incubator/Accelerator | Alive

About Athlomics

Athlomics is commercializing a patented panel of biomarkers which can potentially be used as a point-of-care (POC) blood test for monitoring immune status and health in humans and animals. The company is currently commercializing a blood test to distinguish between sepsis and systemic non-septic inflammation in human patients, particularly in immuno-compromised patients. Athlomics is also conducting contract R&D using its technology for a US partner in the development of new immuno-stimulant products for horses.

Headquarters Location

PO Box 126

NSW 2138,

Australia

Missing: Athlomics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Athlomics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Athlomics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Athlomics is included in 1 Expert Collection, including Health Monitoring & Diagnostics.

H

Health Monitoring & Diagnostics

702 items

Companies developing technology to facilitate near-patient and point-of-care (POC) in vitro diagnostic testing. Companies tagged as #NearPatient&POCTesting

Athlomics Patents

Athlomics has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/15/2005

12/6/2011

Viral plant pathogens and diseases, Chronic fatigue syndrome, Medical signs, Animal virology, Animal viral diseases

Grant

Application Date

8/15/2005

Grant Date

12/6/2011

Title

Related Topics

Viral plant pathogens and diseases, Chronic fatigue syndrome, Medical signs, Animal virology, Animal viral diseases

Status

Grant

Athlomics Frequently Asked Questions (FAQ)

  • What is Athlomics's latest funding round?

    Athlomics's latest funding round is Incubator/Accelerator.

  • Who are the investors of Athlomics?

    Investors of Athlomics include inQbator.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.